Pharmacist’s Misconduct in Codeine Linctus Supply Leads to Conditions Imposed

In a recent determination by the General Pharmaceutical Council (GPhC) Fitness to Practise Committee, a pharmacist was found to have engaged in misconduct related to the supply of codeine linctus. The pharmacist, who was the sole owner and responsible pharmacist at F.F. & R. Stevenson Pharmacy, failed to adequately manage the risks associated with the sale of codeine linctus between July 2017 and September 2020. This included supplying large volumes of the medication without sufficient clinical justification and with knowledge or suspicion that the recipients were misusing the drug.

The allegations centered on the pharmacist’s failure to keep adequate records, monitor sales, and refuse supply in situations where there was potential for misuse or addiction. Specifically, the pharmacist supplied up to 2 x 200ml bottles of codeine linctus to two individuals, Person A and Person B, at frequent intervals, despite suspecting that they were abusing the medication.

The GPhC’s determination on impairment found that the pharmacist’s actions breached several professional standards, including providing person-centred care, using professional judgement, and demonstrating leadership. The pharmacist’s fitness to practise was deemed impaired due to misconduct, posing a potential risk to patients and bringing the profession into disrepute.

As a sanction, the Committee imposed conditions on the pharmacist’s practice for 12 months. These conditions include prohibiting the supply of codeine linctus except to fulfill prescription requirements, confining practice to the specific pharmacy, and undertaking training on the risks associated with pharmacy-only medicines. The pharmacist is also required to provide a record of peer discussion and a reflective account on meeting professional standards.

The case highlights important learning points for pharmacy professionals, emphasizing the need for rigorous risk management, adherence to professional standards, and the importance of maintaining public confidence in the profession. The decision underscores the GPhC’s commitment to protecting public health and maintaining the integrity of the pharmacy profession.